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ABSTRACT 
The major pathogenesis of metabolic syndrome is the development of insulin resistance, 
which promotes the elevation of blood pressure, dyslipidemia, and dysregulation of glucose 
metabolism. Liver is the principal regulator of glucose and lipid metabolism by controlling 
hepatic glucose production, glycogen storage and lipogenesis. Toona sinensis (TS) has been 
reported to be beneficial on health metabolic syndrome, however the effects of TS on liver 
metabolism is not clear. In this study, effects of TS on liver metabolism of high fat diet mice 
were investigated for the underlying mechanism. Mice were fed with high fat diet for 8 weeks 
followed by treatment of TSL-E (100 mg/kg body weight) for 4 weeks. Two-dimensional gel 
electrophoresis followed by mass spectrometry was carried out to identify differential expression 
of liver proteins. In addition, western blot were performed for validation of proteomic analysis. 
Up-regulated expression of genes involved in β-oxidation (PPARα and ACO) was observed in 
liver of TSL-E treated mice. In contract, down-regulated expression of genes was involved in 
lipogenesis (ACC), lipids transport (L-FABP) and decreased expression of proteins was 
involved in gluconeogenesis (Transaldolase, Enolase, PCK2 and Nudix). In conclusion, TS 
mediates its anti-metabolic syndrome potential through improvement of dyslipidemia and blood 
glucose by promoting β-oxidation and inhibiting gluconeogenesis and lipogenesis.  
Keywords: Toona sinensis, β-oxidation, gluconeogenesis, lipogenesis, glycogen synthesis, 2D 
electrophoresis, PPARα/γ, liver, hepatocytes. 
1. INTRODUCTION 
Toona sinensis is well known as antioxidant sources. It has long been used as a traditional 
Chinese medicine for a wide variety of conditions, including rheumatoid arthritis, cervicitis, 
urethritis, tympanitis, gastric ulcers, enteritis, dysentery, itchiness, and cancer. While the 
underlying pharmacological mechanisms of TS remain unclear, various biological activities of 
TS leaf extracts have been reported. Recent scientific investigations demonstrated that aqueous 
leaf extracts of TS possess a variety of biological activities, including antioxidant, anticancer, 
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anti-inflammation, ant diabetes. In the present study, effects of TS on liver metabolism of high 
fat diet mice were investigated for the underlying mechanism. Proteomic analysis provides a 
better understanding of dynamic and overall views of the cell machinery under various 
conditions. Thus, the differentially expressed proteins in liver of mice fed with TSL-E were 
identified by proteomic analysis and confirmed by Western blot. 
2. MATERIALS AND METHODS 
2.1. Reagents and Materials 
The 2-DE reagent including acrylamide solution (25 %) thiourea, immobiline drystrips, 
immobilized pH gradients (IPG) buffer (pH = 3–10), IPG cover mineral oil, iodoacetamide 
(IAA), TEMED, trifluoroacetic acid (TFA), 2-DE clean-up kit, 2-DE Quantkit, and silver 
staining kit were purchased from GEhealthcare (Piscataway, NJ, USA), 3-[(3-cholamidoropyl) 
dimethylammonio]-1propane sulfonate (CHAPS), dithiothreitol (DTT), EDTA, NaF, NaCl, NP-
40, PMSF, sodiumdodecyl sulfate (SDS), tween 20, urea, Na3VO4, methanol (HPLC grade,> 
99.9 %), and sodium deoxycholate were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Protein marker and polyvinylidene fluoride (PVDF) membrane were purchased from Invitrogen 
(Carlsbad, CA, USA). Trisbase and trichloroacetic acid (TCA) were purchased from J. T. Baker 
(Phillipsburg, NJ, USA). The primary and secondary antibodies for Western blotting were 
purchased from Santa Cruz (Santa Cruz, CA, USA). 
2.2. Animals and Treatments  
The C57/B6 mice were purchased from the laboratory animal center of National Cheng 
Kung University, Tainan, Taiwan. All mice were housed alone in standard cages for one week at 
least before the experiments began. Animals were housed in a well-ventilated room maintained 
at 22 ± 2 oC, and 12 h light-dark cycle. After one week of adaptation, obesity animals were 
induced by feeding with high fat diet for next 8 weeks. The high fat diet consisted of food with 
60 % of the calories coming from fat (5.24 kcal/g, 60 % kcal from lard/soybean 9.8:1, D12492; 
Research Diets, New Brunswick NJ). Animals were randomly divided into five groups (n=8) for 
the study: Control: mice were fed with normal diet; HFD: mice were fed with the HFD; PIO: 
mice were fed with the HFD plus pioglitazones; TSL-E: mice were fed with HFD plus TSL-E 
and PIO+TSL-E: mice were fed with the HFD plus pioglitazone and TSL-E. All animals were 
fed with 5 g of food chow (LabDiet, Cat. No. 5001) mixed with or without the TSL extracts for 
8 weeks. Additional normal food chow and sterilized distilled water were supplied ad libitum 
while the TSL extract contained food chow was consumed completely. Animals were sacrificed 
with CO2 at the end-point of this experiment, liver were isolated immediately and stored at -30 
to -80 0C for further analysis.  
Body weight changes were measured each week from the start point of the experiments to 
the end point of experiments. The levels of serum cholesterol (Cho), triglycerides (TG) were 
determined using an automatic blood chemistry analyzer Dry-Chem 4000i (Fujifilm, Saitama, 
Japan). Blood glucose concentrations were determined by a blood glucose meter (Accu-Check 
Advantage, Roche).  
2.3. Preparation of TSL extracts 
The lyophilized extracts of TSL (1 g) purchased from the Taiwan Toona Biotech Corp 
(Kaohsiung, Taiwan) were dissolved in 10 mL of ethanol (95 %) and shaken at room 
temperature for 12 h. Crude extracts were collected from the supernatant and then concentrated 
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by using a vacuum freeze-dryer. The TSL-E powder was collected and stored in the dark at room 
temperature for the following assays.  
2.4. Cell culture 
FL83B hepatocyte is a gift of Professor Lee-Yan-Sheen in National Taiwan University. The 
cells were incubated in F12K medium containing FBS 10 % and penicillin and streptomycin 1 % 
in 10 cm petri dishes at 37 0C and CO2 5 %. Experiments were performed on cells that were 80–
90 % confluent. 
2.5. Protein extraction and qualification 
Cells were washed by PBS and collected scraping in lysis buffer (Sucrose 0,32 M, KH2PO4 
10 mM, Na3VO4 1 mM; PMSF2 mM; EDTA 1 mM; NaF 1 mM, pH 7.4). After incubation on ice 
for 30 minutes, lysates were collected by centrifugation at 10,000 rpm for 30 minutes at 4 0C. 
Protein concentration was estimated by Bradford method. The protein assay dye reagent 
concentrate (BioRad) was diluted 5 fold with distilled water. BSA protein standard was diluted 
to 800, 400, 200, 100, 50, 25, 0 µg/mL with 50 mM phosphate buffer saline (PBS). The 
concentrations PBS diluted protein samples were controlled in the standard curve range. Diluted 
protein samples 10 µl and BSA protein standard were added to protein assay dye reagent, 
transferred to the ELISA plate. The OD 595 nm was read by Tecan Sunrise machine. 
2.6. Electrophoresis and blotting 
Equal amounts 20 µg of total proteins were electrophorylated on SDS-PAGE 10 % and 
transferred to polyvinylidene difluoride (PVDF) membrane. The membrane was blocked with 
nonfat dried milk 5 % in TBST buffer (tris-HCl 20 mM, pH 7.4, NaCl 150 mM, tween 20 0.1 %) 
for 1 hour then hybridized with specific primary antibody overnight at 4 0C. Subsequently, the 
membrane was washed with TBST buffer and incubated with secondary antibodies for 1 hour. 
Protein bands were visualized by enhanced chemiluminescence kits (ECL Plus, Amersham). The 
band quantification was performed using LAS-3000 (Fujifilm, Tokyo, Japan) and Multi Gauge 
software v 3.0 (Fujifilm). 
2.7. Two-dimensions electrophoresis 
For preparation of total protein extract, frozen liver tissue 100 mg were homogenized in 
lysis buffer 0.5 ml consisting of urea 7 M, thiourea 2 M, and CHAPS 4 %,Tris–HCl 25 mM, 
DTT 50 mM, and protease inhibitor cocktail 1 % v/v (Sigma–Aldrich) using homogenizer. 
Samples were centrifuged at 13,000 rpm at 4 0C for 20 minutes. The supernatants containing the 
total liver proteins were removed the contaminants by using a 2 DE Clean-Up Kit (GE 
Healthcare, United Kingdom).The protein concentrations of the extracts were determined by 
Protein Assay Kit (Bio-Rad Laboratories). 2-DE was performed in triplicate for three mice in 
each experimental group. First, using the protocol recommended by the manufacturer, IPG IEF 
of samples was carried out on pH 3 ~ 10, 13 cm IPG DryStrips. IPG strips were passively 
rehydrated overnight in strip holders in rehydration solution 250 µL containing 50 µg of the liver 
protein sample. 
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2.8. Measurement of MMP Level  
FL83B cells were collected in PBS. A Beckman-Coulter Epics XL-MCL Analyzer 
(Beckman-Coulter, Hialeah, FL) equipped with a single 488 nm excitation source was used for 
all flow cytometric analyses. DiOC6, a lipophilic, cationic, fluorescent probe, can bind to 
mitochondrial inner membrane and be used for quantitative measurement of MMP. Fl83B cells 
were incubated with 4 nmol/L DiOC6 at 37 0C for 15 min. The level of MMP was measured as 
an increase in FL1 on a log scale for 5000–10,000 events. 
2. RESULTS 
3.1. Effect of TSL-E on body weight, triglyceride content, serum cholesterol and serum 
glucose in HFD mice  
At the end of the treatment period, the HFD mice were overweight compared with the 
control. The HFD+TSL-E mice, on the other hand, were lighter than the HFD animals, reaching 
a body weight not different from that of the control animals (Figure 1). Serum glucose level was 
higher in HFD mice than in control mice, whereas in HFD+TSL-E animals it was reduced at the 
end of the treatment period (Figure 2A), respectively. However, HFD mice exhibited 
significantly elevated levels of the plasma triglyceride and serum cholesterol and HFD+TSL-E 
was not significantly different from that of HFD mice (Figure 2B, 2C).   
 
Figure 1. Effect of TSL-E on body weight of HFD mice.  
C57BL/6 mice were fed with HFD for 8 weeks to induce obese then treated with TSL-E for 
6 weeks. The body weight was determined each week. Body weight was set 100 % as the body 
weight at the first week. At the end of treatment period, body weight of HFD mice were raised 
significantly, up to 5 % compared with the control. TSL-E feeding HFD mice restored the body 
weight to normal level of control mice.   
C57BL/6 mice were fed with HFD for 8 weeks to induce obese then treated with TSL-E for 
6 weeks. The serum glucose (GLU) (A), serum triglyceride (TG) (B) and serum cholesterol 
(Chol) (C) were determined each week. HFD mice increased triglyceride, cholesterol and 
glucose level compared with control mice. 
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Figure 2. Effect of TSL-E treatment on serum glucose, triglyceride and cholesterol level of HFD mice. 
3.2. Proteomic profiling of TSL-E regulated protein on liver of HFD mice  
To gain insight into TSL-E effects on liver metabolism of HFD mice, we subjected liver of 
HFD; HFD treated with TSL-E and control mice to 2D-E and MS proteomics because liver is 
the major site for glucose and lipid metabolism. TSL-E groups showed the highest number of 
protein spots, respectively (1195 spots), while control and HFD groups just showed 876 and 815 
protein spots (Figure 3). Compared control groups with TSL-E groups there were 179 spots were 
up regulation and 185 spots were down regulated. Similarly, compared TSL-E groups with the 
HFD groups, 174 spots were up regulated and 190 spots were down regulated. Compared with 
control groups, HFD groups showed the highest spots up regulation (186 spots) but lowest spots 
down regulation (178 spots). Differentially expressed proteins in livers of control, HFD, and 
HFD+TSL-E mice were identified by mass spectrometry and reported in Table 1. Additional 
experimental details for mass spectrometry identifications are reported in Table 2.  
 
 
Figure 3. The 2D-E images obtained from the liver of control, HFD mice and HFD + TSL-E groups. 
Representative 2D-E images obtained from liver protein of mice in control group (A), HFD 
group (B) and HFD+TSL-E(C). 2D-E was performed using a nonlinear pH range of 3–10 in the 
first dimension (13cm strips) and SDS-PAGE (12 %) in the second. Protein loading was 60 g, 
and the gels were stained using silver. Identified protein spots among those with a density that 
differed significantly between experimental groups (P < 0.05) are marked and numbered.  
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Table 1. Mass spectrometry identified of the significant difference protein in liver. 
No 
spot 
Swissprot 
accession 
Protein name P value 
(Between groups) 
Relative expression 
(Control:HFD:TSL-E) 
1 gi|6678499 UDP-glucose 6-dehydrogenase P<0.001 1:2.4:0.7 
2 gi|387144 Muscle-specific enolase beta subunit 0.026 1:1.7:1.1 
3 gi|148686112 Transaldolase 1 0.098 1:0.6:2.3 
4 gi|1009706 Sorbitol dehydrogenase precursor 0.085 1:1.65:1.1 
5 gi|21706762 Nudix (nucleoside diphosphate linked 
moiety X)-type motif 9 [Mus musculus] 
0.017 1:4.2:1.2 
6 gi3452686 Protein kinase C lambda [Mus 
musculus] 
0.025 1:0.4:1.1 
7 gi|31982522 Short-chain specific acyl-CoA 
dehydrogenase 
P<0.001 1:1.7:0.7 
8 gi|13097375 Electron transferring flavoprotein, alpha 
polypeptide  
0.009 1:2.2:1 
9 gi|8393343 Fatty acid-binding protein 0.003 1:3.2:2.9 
10 gi|191804 Aldehyde dehydrogenase II 0.023 1:0.3:1.2 
11 gi|17391295 Hspd1 protein  0.005 1:1.2:0.8 
12 gi|55925018 Catalase 0.001 1:2:0.8 
13 gi|31560686 Heat shock-related 70 kDa protein 2  0.036 1:1.4:0.7 
14 gi|6671549 Peroxiredoxin-6 [Mus musculus] 0.048 1:0.5:1.3 
15 gi|148692928 Glutamate dehydrogenase 1 P<0.001 1:2:0.5 
16 gi|1841443 Glutamine synthase 0.002 1:0.5:2.7 
17 gi|19526790 S-adenosylmethionine synthase isoform 
type-1 
0.019 1:0.8:1.5 
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Table 2. Mascot - identified differentially expressed protein in liver of mice. 
 
No Protein name Mass Score Matches Sequences emPAI pI 
1 Heat shock-related 70 kDa protein 2  69599 778 40(22) 9(5) 0.52 5.51  
2 UDP-glucose 6-dehydrogenase 54797 104 3(2) 3(2) 0.14 7.49 
3 Catalase 4375 90 3(0) 2(0) 1.04 9.42 
4 Transaldolase 1 19251 28  1(0)  1(0) 0.20 9.18 
5 Glutamate dehydrogenase 1 54185 255  29(10) 9(4) 0.95 7.66 
6 Muscle-specific enolase β subunit 40680  112 1(1) 1(1) 0.09 6.45 
7 Short-chain specific acyl-CoA 
dehydrogenase 
44861 95 2(1) 2(1) 0.08 8.68 
8 Electron transfer flavor protein  35018  746   27(19) 8(4) 1.27 8.62 
9 Fatty acid-binding protein 14236 294 13(9) 7(4) 8.11 8.59 
10 Protein kinase C lambda  67156 35  1(0) 1(0) 0.06 5.53 
11 Glutamine Synthase 42162 141 6(3) 5(2) 0.29 6.57 
12 Hspd1 protein  26998 137 10 (4) 3(2) 0.69 4.76 
13 Nudix (nucleoside diphosphate linked 
moiety X)-type motif 9 
38599 29  1(1) 1(1) 0.1 6.39 
14 Peroxiredoxin-6 24811 153 12(8) 6(3) 1.63 5.98 
15 Aldehyde dehydrogenase II 54447 109 7(3) 4(2) 0.22 7.89 
16 S-adenosylmethionine synthase isoform 
type-1 
43481 297 9(6) 3(1) 0.09 5.51 
17 Sorbitol dehydrogenase precursor 40066 151 19(5) 7(3) 0.43 6.60 
Mass spectrometry identified the differentially expressed proteins in livers of control, HFD, 
and HFD+TSL-E mice. Accession number, protein name and cellular role are reported according 
to Swiss-Prot database. Differential expression (P < 0.05) were identified by anova-test. Values 
were calculated by comparing mean relative intensity (RI) values between spots within the same 
experiment (representative analysis set, n = 4). Mascot identified differentially expressed 
proteins in livers of control, HFD, and HFD+TSL-E mice. Protein name, the predicted molecular 
mass, pI are reported according to Mascot search result. 
When our interest was limited to differential expressions of at least 2-fold and a statistical 
significance of at least 95 % (P < 0.05), the counts were 17 protein spots, respectively. These 
proteins can be separated into 4 groups: anti-oxidative stress, lipid metabolism, glucose 
homeostatic, nitrogen and amino acid metabolism. TSL-E showed the anti-oxidation effects by 
revealing the protein expressions of heat shock-related 70 kDa protein 2 (Hsp70), Hspd1, 
peroxiredoxin 6 (Prdx 6), CAT, nudix (nucleoside diphosphate linked moiety X)-type motif 9 
(NUDT9) and aldehyde dehydrogenase (ALDH). Glucose metabolism related proteins included 
UDP-glucose 6-dehydrogenase (UGDH), muscle-specific enolase β subunit (MSE), sorbitol 
dehydrogenase precursor (SDH), transaldolase (TAL). TSL-E affected lipid metabolism by 
altering the protein expression of short-chain specific acyl-CoA dehydrogenase (SCAD), 
electron transfer flavor protein (ETF), fatty acid-binding protein (FABP). The expressions of s-
adenosylmethionine synthase (SAM), glutamate dehydrogenase (GLDH) and glutamine synthase 
(GS) were alternated by TSL-E indicating that TSL-E also effect nitrogen metabolism in liver.   
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3.3. Effect of TSL-E on PPARα, PPARγ, PCK2 and HMG-CoA protein expression in liver 
of mice   
PPARα and PPARγ are members of the PPAR family of nuclear transcription receptors and 
play a central role in glucose metabolism, lipid biosynthesis and insulin sensitivity. 
Phosphoenolpyruvate carboxykinase 2 (PCK2) is a key enzyme on gluconeogenesis pathway. 3-
hydroxy-3-methylglutaryl coenzyme A synthase (HMG-CS) contains an important catalytic 
cysteine residue that acts as a nucleophile in the first step of reaction: the acetylation of enzyme 
by acetyl-CoA to release the reduced coenzyme A. HMG-CS is an intermediate in both 
cholesterol synthesis and ketogenesis. To investigate the effects of TSL-E on glucose and lipid 
metabolism, the Western blot was used to identify the expression of PPARα, PPARα, PCK2 and 
HMG-CS in liver of mice. 
As shown in Figure 4A and 4B, PPARα and PPARγ protein expression were up regulated 
in HFD mice. Interestingly, the PPARα and PPARγ expression were higher in TSL-E treatment 
compared with that of HFD mice. PIO, a full PPARγ agonist significantly increased the PPARγ 
expression. The PPARα expression in TSL-E treatment was higher than that in PIO treatment 
while the PPARγ expression in TSL-E was lower than that in PIO treatment. Combined TSL-E 
and PIO did not change the PPARγ expression but significantly increased PPARα expression. 
HFD and HFD+PIO elevated the PCK2 protein expression in liver (Figure 4C). TSL-E treatment 
decreased the expression of PCK2 compared with HFD and HFD+PIO, respectively. TSL-E 
combined PIO also decreased PCK2 expression compared with PIO only. HFD up regulated the 
HMG-CS expression (Figure 4D). The expression of HMG-CS in HFD fed TSL-E were elevated 
and up to a level higher than that in HFD mice. TSL-E combined PIO decreased HMG-CS 
protein expression in liver of mice compared with TSL-E only.  
  
Figure 4. The protein expression of PPARα, PPARγ, PCK2 and HMG-CoA in liver. 
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Control: mice were fed with normal diet; HFD: mice were fed with the HFD; PIO: mice 
were fed with the HFD plus pioglitazones (5 mg/kg body weight); TSL-E: mice were fed with 
HFD plus TSL-E (0.5 g/kg body weight) and PIO+TSL-E: mice were fed with the high-fat diet 
plus pioglitazone and TSL-E. TSL-E increased the protein expression of PPARα and PPARγ. 
Data are expressed as means plus standard deviations of three similar experiments. The data are 
given as means ± SE. a, b, c, d: bars with superscripts without a common letter differ 
significantly (student t test, P < 0.05).   
 
4. DISCUSIONS 
4.1. TSL-E improved liver metabolism by suppressed the elevated of gluconeogenesis and 
increased lipolysis in liver of HFD mice 
4.1.1. TSL-E suppressed the elevated of gluconeogenesis in liver of HFD mice 
HFD have been used as model for obesity, dyslipidaemia and IR in rodents for many 
decades [1]. Our model with HFD was pronounced obesity which increased body weight at the 
end of treatment period (Figure 1). We found that numerous enzymes associated with 
gluconeogenesis were increased in liver of HFD mice and normalized in HFD+TSL-E mice 
including UGDH, ETF and SDH. UGDH provides cursors for an array of extracellular matrix 
glycosaminoglycans such as heparin and hyaluronic acid, and also catalyzes the crucial 
structural modification of xenobiotic toxins required for their eventual eliminations [2]. 
Disturbed metabolism of glycosaminoglycans (GAGs) has been proposed to play an important 
role in the pathogenesis of diabetic complications [3]. Via UDP-glucose, glucose flux from 
gluconeogenesis was converted to glycosaminoglycans or glycogen. In the present study, HFD 
increased UGDH, and HFD+TSL-E restored UGDH to normal level. SDH is a member of the 
super family of medium chain dehydrogenases/reductases. SDH, the second enzyme in the 
polyol pathway, oxidizes sorbitol to fructose in the presence of NAD. Fructose is converted to 
glucose by the way of gluconeogenesis through condensation of triose- phosphate to fructose 1, 
6 biphosphate. Recent studies have shown that flux via polyol pathway enzymes aldose 
reductase and sorbitol dehydrogenase is required to mediate hypertension complications of 
diabetes [4]. Oxidation of sorbitol to fructose by SDH causes oxidative stress because its co-
factor NAD+ is converted to NADH and NADH is the substrate for NAD(P)H oxidase to 
generate ROS [5]. Caffeic acid (CA) and ellagic acid (EA) at 5 % mediated its anti-diabetes 
effects by decreased the levels of sorbitol dehydrogenase [6]. In this study, HFD increased SDH 
and HFD+TSL-E restored to normal level of SDH suggested that TSL-E might inhibit the 
activation of polyol pathway in HFD condition. 
β-oxidation represents an important source of energy for the body during times of fasting 
and metabolic stress, providing carbon substrates for gluconeogenesis and contributing with 
electrons to the respiratory chain for energy production. Increased transfer of electrons from 
reducing equivalents generated by β-oxidation could contribute to increased mitochondrial ROS 
generation [7]. HFD mice increased EFT expression that contributed to increase oxidation and 
gluconeogenesis and HFD+TSL-E decreased EFT expression in liver. Moreover, HFD decreased 
TAL and HFD+TSL-E increased the expression of TAL. Our results indicated that TSL-E 
decreased gluconeogenesis via increased TAL expression in HFD mice. With respect to 
gluconeogenesis there was a large increase in a key steps, PCK2 have been confirmed by using 
Western blot. The PCK2 expression in liver of HFD mice was significantly increased (Figure 4) 
and HDF+TSL-E decreased the expression of PCK2 compared with HFD and HFD+PIO groups.  
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Hepatic gluconeogenesis contributes to elevation of fasting glucose. Hyperglycemia in type 
2 diabetes is characterized by enhanced glucose production in the liver. In the presence of IR, 
enhanced glucose output by liver contributes to hyperglycemia. Inhibition of hepatic glucose 
production contributes to glycemic control in the diabetic patients by insulin sensitizers. Several 
reports have documented that inhibited or decreased gluconeogenesis has benefit in patients with 
type 2 diabetes and IR suggesting that TSL-E can be used as a therapy for type 2 diabetes 
patients.  
4.1.2. TSL-E increased lipolysis in liver of HFD mice 
The protein expression of FABP was increased in both HFD and HFD+TSL-E mice (Table 
1). FABP transfer fatty acids between extra- and intracellular membranes. Expression of FABP 
is regulated by dietary long chain fatty acid (LCFA) as well as by stimulating mitochondrial and 
peroxisomal oxidation of LCFAs [8]. FABP physically interacts with PPARα and functionally 
interacts with both PPARα and PPARγ [9].  
SCAD plays a pivotal role in energy metabolism providing fuel after prolonged starvation 
or during periods of increased energy requirements [10]. Although HFD+TSL-E decreased the 
protein expression of SCAD compared with HFD, the β-oxidation was up regulated in 
HFD+TSL-E feeding mice. Indeed, PPARα regulates mRNA expression of genes involved in 
FA oxidation, and synthetic PPARα agonists decrease circulating lipid levels and are commonly 
used to treat hyperlipidemia and other dyslipidemic states [11]. The PPARα expression in 
HFD+TSL-E was higher in HFD mice. Similarly, HFD+TSL-E significantly increased the 
expression of HMG-CSprotein in liver of mice. Due to FABP and HMG-CS are target genes of 
PPARα, the activation of PPARα leads to up regulation of FABP and HMG-CS. FABP 
enhances cellular LCFA uptake, enhances intracellular transport/diffusion through the cytoplasm 
and targets LCFA to peroxisomes for β-oxidation generate acetyl-CoA. Acetyl-CoA is the 
product of β-oxidation and is passed into of the tricarboxylic acid (TCA) cycle for the 
production of additional adenosine triphosphate (ATP) or is used for the production of ketones 
under the expression of HMG-CS. 
IR in HFD has recorded increasing de novo lipogenesis [12]. However, de novo hepatic 
lipogenesis was normally contributed by a minor portion to total hepatic triglyceride synthesis. 
Increased plasma FFA levels may result in intracellular accumulation of lipid metabolites in the 
liver, leading to fatty liver, liver IR and type 2 diabetes [13]. Therefore, one potential strategy for 
improving metabolic syndrome is not only to reduce the level of plasma FFA, but also to oxidize 
instead of accumulates intracellular TG in the liver. TSL-E does not decrease lipogenesis but 
enhance lipolysis in liver of HFD suggesting that TSL-E may have benefit in metabolic 
syndrome. 
4.2. TSL-E decreased oxidative stress in liver of HFD diet mice 
Under the oxidative stress of HFD, the mice increased the expression of anti-oxidation 
protein included Hsp70, CAT, Prdx 6 and NUDT9.  
CAT is enzyme that catalyzes the decomposition of hydrogen peroxide to water and 
oxygen, protecting cells. Feeding mice with HFD caused a significant increase in the activity of 
CAT. HFD increase oxidation of fatty acids through the peroxisomal oxidation pathway that is 
associated with increased generation of hydrogen peroxide. Therefore, the increased activity of 
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CAT would suggest a compensatory response of hepatic defense system under condition of 
enhanced H2O2 generation. 
Hsp70 are central components of the cellular network of molecular chaperones and folding 
catalysts. Hsp70 assist a wide range of folding processes, including the folding and assembly of 
newly synthesized proteins, refolding of misfolded and aggregated proteins, membrane 
translocation of organelle and secretory proteins, and control of the activity of regulatory 
proteins [14]. A few studies involving overexpression of Hsp70 in cell lines have shown 
protection against heat shock and oxidative stress. Hsp70 levels in the mononuclear cells are 
elevated reflecting increased oxidative stress in patients with diabetes [15]. Hsp70 is thought to 
be beneficial in defending against oxidative injury. But if overexpression of Hsp70 continues, 
the ability to respond to subsequent stressful conditions such as aging, exposure to oxidizing 
chemicals or reduced antioxidants may be impaired. In diabetes, continuous hyperglycemia, or 
attenuated activities of anti-oxidative enzymes may cause chronic overexpression of Hsp70 and 
subsequent reduction of the ability to cope with stressful conditions. In our results, HFD 
increased Hsp70 protein expression and HFD+TSL-E normalized to the level of control groups 
suggested that the stress condition in HFD were decreased under TSL-E treatment. 
The peroxiredoxins, belong to the rapidly growing family of the thiol-specific antioxidant 
proteins that are highly conserved from bacteria to mammals. Prdx6 uses glutathione and 
ascorbate as electron donors and is the only member of the Prdx family that has the ability to 
remove H2O2 and phospholipid hydroperoxide and is, therefore, able to reduce the accumulation 
of phospholipid hydroperoxides in plasma membranes [16]. Previous study has been reported 
that HFD induced the decreased expression of genes associated with antioxidant defense, such as 
superoxide dismutase-3, metallothionein-1, glutathione peroxidase-5, and Prdx 6 [17]. 
Consistently, in our study HFD decreased the expression of Prdx 6 and HFD+TSL-E significant 
increased Prdx 6 expression in liver of HFD mice. 
Moreover, S-adenosylmethionine synthesis is the first step in methionine metabolism in a 
reaction catalyzed by methionine adenosyl transferase. SAM is the principal biologic methyl 
donor, the precursor for polyamine bio synthesis and a precursor of glutathione (GSH) by means 
of the transulfuration pathway. The increase of SAM can lead to increase homocyteine, therefore 
increase the generation of glutathione. The beneficial effect of SAM in preservation solutions 
could therefore include direct radical scavenging as well as acting as a precursor for intracellular 
GSH [18]. Recently, Fonseca V. et al. were able to demonstrate that the PPAR agonist 
troglitazone had significant increases in hepatic concentrations of S-adenosylhomocysteine 
(SAH) and S-adenosylmethionine (SAM) plus SAH. Additionally, there was a significant 
decline in the SAM/SAH ratio. In our result, TSL-E treatment increased the SAM level 
compared with both control and HFD group indicated that the anti-oxidative stress activity of 
TSL-E might through the increase the GSH level in liver. 
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Figure 5. Effect of TSL-E on MMP of FL83B cell treated oleic acid induced oxidative stress. 
The FL83B hepatocytes were cultured in normal condition (M1), treated with 200 µM OA 
(M2) treated with TSL after added OA (M3, M4) or pretreated with TSL-E before added OA 
(M5, M60combine with the TSL-E treatment (pretreat and treatment). * P < 0.05, Student’s t test. 
Mitochondrial aldehyde dehydrogenase is responsible for metabolizing of ethanol and their 
activities contribute to the rate of ethanol elimination from the blood [19]. Ethanol metabolism 
also produces reactive species, including acetaldehyde and free radicals, which can directly 
attack proteins, lipids, and many other cellular components. Diabetic rats exhibited significantly 
increased ROS, accompanied by decreasing in ALDH2 activity and expression [20]. In our 
study, HFD decreased the ALDH2 expression and after fed with TSL-E, ALDH2 was 
significantly increased, restored to normal level. This result also confirmed the anti-oxidation 
effect of TSL-E on the liver of high fat mice. 
Mitochondria are considered as the main source of ROS in the cell. The ability of ROS-
mediated oxidative stress has been associated with lipid peroxidation and loss of MMP [21]. 
Moreover, the damage to the mitochondrial compartment might be the toxic effect of 
accumulation of compounds that are normally degraded by peroxisomal β-oxidation, particularly 
by fatty acids. To confirm the anti-oxidation effect of TSL-E, we investigated the effect of TSL-
E on MMP in HepG2 using flow cytometry with DiCO6 dye. While OA caused loss of MMP, 
the TSL-E treatment restored it indicated that under anti-oxidative activity of TSL-E, the ROS 
induced by OA were decreased associated with meliorated the MMP level (Figure 5).  
Taken together, TSL-E showed the anti-oxidation activity by increasing the expression of 
Prdx6 and its glutathione supply S-adenosine methionine. The increase of Prdx6 suppressed the 
elevated of H2O2 generation in HFD mice, since restored to normal level of CAT, Hsp70 
proteins expression. This results is consistent with previous documentation that protein oxidation 
and oxidative damage have been previously associated with diabetes [22] and TSL-E have anti-
oxidation activity. 
Since alterations in oxidative capacity and mitochondrial functions may have an important 
role to play in the pathophysiology of diets induced obesity and its complications. HFD is 
redirected into harmful pathways of non-oxidative metabolism with intracellular accumulations 
of toxic metabolites. The present results provide further evidence that TSL-E supplement, while 
improve dyslipidemia effects, may furnish protection against diet-induced liver damage, possibly 
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by reducing oxidative stress. In previous study in our lab, we also found that Toona sinensis 
extracted exhibited the ant oxidative effect which increased the enzyme activities of CAT, 
cupper/zinc superoxide dismutase (Cu/Zn SOD), glutathione peroxidase (GPx), glutathione 
reductase (GR), and Glutathione S transferase (GST) activities in liver [23], this study supported 
another evident to confirm anti-oxidation activity of TSL-E. 
4.3. Proposed pathway of TSL-E effect on HFD 
PPARα regulates genes involves in fatty acid uptake and oxidation, inflammation, and 
vascular function and plays a central role in fatty acid catabolism in liver and other tissues by 
up-regulating beta- and delta-oxidation [24]. PPARγ ligands are particularly interesting for 
treating type 2 diabetes mellitus because they restore sensitivity to insulin, increasing glucose 
uptake into liver and skeletal muscle cells and reducing plasma glucose levels. By promoted β-
oxidation via PPARα activity, TSL-E decreased gluconeogenesis which elevated in HFD mice 
caused hypertension and IR. PPARα activation also controls hyperlipidemia in HFD mice by 
decreased lipogenesis. While PCK2 protein expression is elevated in HFD mice, the TSL-E 
treatment decreased PCK2 compared with HFD groups. These results suggest that TSL-E is 
more efficient activity on PPARα relative to PPARγ. The interaction between PPARα and 
PPARγ agonist activity of TSL-E can alleviate side effect, such as increased body weight 
associated with PPARγ agonists. The classic full PPARγ agonists have a variety of side effect, 
chiefly weight gain due to edema and increased fat mass [25]. However, the side effect 
associated with PPARγ activation may be circumvented through the combined activation of 
PPARα and PPARγ, which is known to result in a complementary and synergistic increase in 
lipid metabolism and insulin sensitivity [26]. In summary, TSL-E might manipulate the lipolysis 
and energy homeostasis in liver through the regulation of PPARα/γ downstream signaling 
pathway.  
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TÓM TẮT 
PHÂN TÍCH PROTEOMICS MÔ GAN CHUỘT NHẮT CHO ĂN VỚI HÀM LƯỢNG 
CHẤT BÉO CAO TRONG SỰ ĐÁP ỨNG VỚI DỊCH CHIẾT BẰNG CỒN CỦA LÁ CÂY 
TÔNG DÙ (TOONA SINENSIS ROEM) 
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Trường Đại học Bách khoa, Đại học Đà Nẵng, 54 Nguyễn Lương Bằng, Đà Nẵng 
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 Các bệnh sinh chủ yếu của hội chứng chuyển hóa là sự phát triển kháng insulin, thúc đẩy sự 
tăng huyết áp, rối loạn mỡ máu và rối loạn chuyển hóa đường. Gan là cơ quan chính của chuyển 
hóa đường và chất béo bằng cách kiểm soát sản xuất glucose, lưu trữ glycogen và sinh tổng hợp 
chất béo. Nhiều nghiên cứu đã cho thấy rằng cây tông dù tác dụng tốt lên bệnh nhân mắc bệnh 
rối loại chuyển hóa, tuy nhiên ảnh hưởng của cây tông dù lên hoạt động của gan chưa được 
nghiên cứu rõ ràng. Nghiên cứu này nhằm làm rõ ảnh hưởng  dịch chiết cây tông dù lên quá 
trình sinh tổng hợp của gan chuột nhắt được cho ăn với hàm lượng chất béo cao. Chuột nhắt 
được cho ăn với lượng chất béo cao trong 8 tuần để gây rối loạn chuyển hóa, sau đó chuột được 
cho ăn thức ăn có bổ sung dịch chiết tông dù (100 mg/kg) trong 4 tuần. Chúng tôi sử dụng kỹ 
thuật phân tích điện di 2 chiều kết hợp với sắc kí khối phổ để xác định sự biểu hiện của các 
protein mô gan chuột. Ngoài ra, kỹ thuật lai Western cũng được thực hiện để kiểm tra kết quả 
của phân tích proteomics. Kết quả cho thấy, có sự gia tăng biểu hiện của các gen liên quan quá 
trình oxi hóa beta (PPARα và ACO) và ngược lại, giảm biểu hiện của các gen liên quan quá 
trình sinh tổng hợp chất béo (ACC), vận chuyển chất béo (l-FABP) và quá trình sinh tổng hợp 
đường (Transaldolase, Enolase, PCK2 and Nudix). Có thể kết luận rằng, dịch chiết bằng cồn của 
lá cây tông dù có tiềm năng kháng lại hội chứng chuyển hóa thông qua sự cải thiện rối loạn 
chuyển hóa mỡ và đường máu bằng cách tăng cường quá trình oxi hóa beta và làm giảm sinh 
tổng hợp đường và chất béo. 
Từ khóa: cây tông dù, oxi hóa beta, sinh tổng hợp đường, sinh tổng hợp chất béo, sinh tổng hợp 
glycogen, PPARα/γ, gan, tế bào gan. 
 
 
